Results 91 to 100 of about 179,953 (145)

Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastoma With an Unusual EWSR1::RAD51B Gene Fusion: A Case Report and Review of the Literature. [PDF]

Cureus
Al-Mustafa S, Al-Kawaaz M, Paul L, Franchitti A, Aldape KM, Hattab EM.   +5 more
europepmc   +1 more source

Evaluation of zooplankton potential CO2 production: isocitrate dehydrogenase (IDH) enzyme activity

, 2016
Isocitrate dehydrogenase (IDH), a CO2 producing enzyme, plays a key role in the Krebs cycle, being responsible for the emission of one of the three CO2 molecules related to this central phase of cellular respiration.
Tames-Espinosa, Mayte, Packard, Theodore T., Martínez, Ico, Gómez, May   +3 more
core  

Right Frontal Isocitrate Dehydrogenase (IDH)-Mutant WHO Grade 3 Oligodendroglioma Presenting With Morning Headache and Gait Imbalance. [PDF]

Cureus
Metwaly L.
europepmc   +1 more source

Molecular Targeting of the Isocitrate Dehydrogenase Pathway and the Implications for Cancer Therapy

The advent of comprehensive genomic profiling using next-generation sequencing (NGS) has unveiled an abundance of potentially actionable genetic aberrations that have shaped our understanding of the cancer biology landscape. Isocitrate dehydrogenase (IDH)
Amalia Bonano-Rios, Stanislav Ivanov, Olger Nano, Atif Hussein, Caroline Hana   +4 more
core   +1 more source

Outcome of Acute Myeloid Leukemia Treatment and Isocitrate Dehydrogenase (IDH) Mutations: A Systematic Review and Meta-Analysis Study. [PDF]

Int J Hematol Oncol Stem Cell Res
Ameli F, Abdollahi A, Salarvand S, Ghasemi D.   +3 more
europepmc   +1 more source

Early Non-Contiguous Pachymeningeal Dissemination of Isocitrate Dehydrogenase (IDH)-Wildtype Giant Cell Glioblastoma: A Rare Finding During Adjuvant Therapy. [PDF]

Cureus
Galli EG, Spanu F, Emanuele L, De Lucia V, Cagetti B.   +4 more
europepmc   +1 more source

Isocitrate Dehydrogenase Inhibitors in Glioma: From Bench to Bedside

Isocitrate dehydrogenase (IDH) mutant gliomas are a primary malignancy of the central nervous system (CNS) malignancies, most commonly affecting adults under the age of 55.
Merve Hazal Ser, Mason Webb, Anna Thomsen, Ugur Sener   +3 more
core   +1 more source

Clinical advancement in the management of mutant isocitrate dehydrogenase (<i>IDH</i>) cancers. [PDF]

EJC Suppl
Bridgewater J, Tabatabai G, Macarulla T, Stacchiotti S.   +3 more
europepmc   +1 more source

Characteristics of [¹⁸F]FET PET and MRI in isocitrate dehydrogenase (IDH)-mutant gliomas diagnosed according to the WHO 2021 classification - a retrospective analysis. [PDF]

Eur J Nucl Med Mol Imaging
Barci E, Mair MJ, Reis J, Müller K, Isakaj J, Istrefi E, von Polenz I, Siegmund SC, Kaiser L, Preusser M, Schichor C, Thon N, Harter P, von Baumgarten L, Forbrig R, Albert NL.   +15 more
europepmc   +1 more source

A novel MRI diffusion metric 'slow diffusion coefficient' (SDC) for diagnosing isocitrate dehydrogenase (IDH) genotype in diffuse gliomas: initial promising results. [PDF]

BMC Med Imaging
Zheng WY, Shi YT, He YY, Lin RL, Xiao BH, Jiang RF, Wáng YXJ.   +6 more
europepmc   +1 more source